Summit Therapeutics (SMMT) Stock Price, Quote, News & History | Benzinga

SPY777.54−0.07%QQQ742.87−0.42%BTC/USD83,810.35+0.85%DIA515.75−0.42%GLD380.96−0.31%TLT78.41+0.46%

Summit Therapeutics Inc (SMMT) Stock Price, Quote, News & History

SMMTNASDAQ

Trade with Public

Trade with Public

$15.52

-1.61-9.4%

Last update: Oct 13, 7:50 PM

$15.61

-1.52-8.87%

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$16.79

Close

$15.52

Volume / Avg.

7.13M / 5.80M

Day Range

$15.58 - $15.61

52 Wk Range

12.07 - 29.23

Market Cap

$13.67B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

43

Short Interest

26.3%

Days to Cover

4.84

Recent Summit Therapeutics Inc. News

Chip Stocks Slide as South Korea's KOSPI Plunges, J&J Sinks 6%: Stock Market Today

Chip stocks sold off after a 5% KOSPI plunge, with Micron and Applied Materials sinking, while J&J fell despite a guidance raise.

Piero Cingari

Stock Market Today: S&P 500, Russell 2000 Fall as 30-Year Yield Hits 5.7%

Stocks fell and small caps slumped Wednesday as the 30-year Treasury yield hit 5.7%, a 24-year high, with Fed minutes and bond auctions ahead.

Piero Cingari

Amazon, Alphabet, Tesla Stock Rises: Robinhood Traders Sell Anyway

Amazon, Alphabet and Tesla rose Friday, but Robinhood traders sold all three. The monthly data suggests profit-taking, not an AI trade exit.

Surbhi Jain

AstraZeneca, Daiichi Sankyo Expand Cancer Push Through Summit Partnership

AstraZeneca & Daiichi Sankyo team up with Summit Therapeutics to test Datroway + ivonescimab combo in triple-negative breast cancer.

Vandana Singh

Robinhood Traders Just Went on Their Biggest Buying Binge Ever

Robinhood traders just recorded their biggest five-day buying binge ever, piling into stocks including FICO, SMMT, MDB and NVTS.

Surbhi Jain

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-458.43M

Investing Cash Flow (TTM)

-262.57M

Financing Cash Flow (TTM)

842.51M

Free Cash Flow (TTM)

-459.82M

Capital Expenditure (TTM)

-1.39M

Net Change in Cash (TTM)

121.51M

Analyst Trends and Forecast

1

2

1

May

2

1

Jul

4

Aug

2

1

Sep

1

Oct

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.6

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$13.36B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

21.71

Earnings Yield % (TTM)

-6.47%

Earnings Yield % (FWD)

-6.08%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.79

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$419.37M

Debt to Equity

0.03

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-